Dow Jones

38 798,99

-0,22%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Kite Pharma, Inc. (KITE)
Kite Pharma, Inc. (KITE) Actualités

KITE

KITE PHARMA, INC. (KITE)

Kite Pharma, Inc.

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:KITE

1 2 3 4 5 6 7 8 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
13/10/2017	23h05	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:KITE	Kite Pharma, Inc.
05/10/2017	21h44	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:KITE	Kite Pharma, Inc.
03/10/2017	23h12	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:KITE	Kite Pharma, Inc.
03/10/2017	22h56	Edgar (US Regulatory)	Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)	NASDAQ:KITE	Kite Pharma, Inc.
03/10/2017	22h44	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:KITE	Kite Pharma, Inc.
03/10/2017	15h03	Edgar (US Regulatory)	(25-NSE)	NASDAQ:KITE	Kite Pharma, Inc.
03/10/2017	14h46	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:KITE	Kite Pharma, Inc.
03/10/2017	14h45	Business Wire	Gilead Sciences Completes Acquisition of Kite Pharma, Inc.	NASDAQ:KITE	Kite Pharma, Inc.
03/10/2017	14h17	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:KITE	Kite Pharma, Inc.
03/10/2017	14h00	Business Wire	Gilead Sciences Completes Tender Offer for All Outstanding Shares of Kite Pharma, Inc.	NASDAQ:KITE	Kite Pharma, Inc.
26/09/2017	14h30	Business Wire	Gilead Sciences and Kite Pharma Announce Expiration of Hart-Scott-Rodino Waiting Period	NASDAQ:KITE	Kite Pharma, Inc.
05/09/2017	22h13	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:KITE	Kite Pharma, Inc.
05/09/2017	18h24	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:KITE	Kite Pharma, Inc.
01/09/2017	23h28	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:KITE	Kite Pharma, Inc.
01/09/2017	23h22	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:KITE	Kite Pharma, Inc.
01/09/2017	00h23	PR Newswire (US)	SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Kite Pharma, Inc. - KITE	NASDAQ:KITE	Kite Pharma, Inc.
30/08/2017	18h50	Dow Jones News	FDA Approves First Gene Therapy in U.S. -- Update	NASDAQ:KITE	Kite Pharma, Inc.
30/08/2017	18h25	Dow Jones News	FDA Approves First Gene Therapy in U.S.	NASDAQ:KITE	Kite Pharma, Inc.
30/08/2017	00h46	PR Newswire (US)	Harwood Feffer LLP Announces Investigation of Kite Pharma, Inc.	NASDAQ:KITE	Kite Pharma, Inc.
29/08/2017	09h02	Dow Jones News	Gilead Bets $11 Billion On New Cancer Therapy -- WSJ	NASDAQ:KITE	Kite Pharma, Inc.
29/08/2017	09h02	Dow Jones News	What's News: Business & Finance -- WSJ	NASDAQ:KITE	Kite Pharma, Inc.
29/08/2017	01h56	Dow Jones News	Gilead to Buy Kite Pharma for Roughly $11 Billion -- 2nd Update	NASDAQ:KITE	Kite Pharma, Inc.
28/08/2017	18h26	Dow Jones News	The Promising New Cancer Treatment Behind Gilead's $11 Billion Deal	NASDAQ:KITE	Kite Pharma, Inc.
28/08/2017	17h55	Business Wire	ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Kite Pharma, Inc.	NASDAQ:KITE	Kite Pharma, Inc.
28/08/2017	15h29	Dow Jones News	Hot Stocks to Watch in the U.S. and Canada	NASDAQ:KITE	Kite Pharma, Inc.
28/08/2017	14h46	Dow Jones News	Gilead to Buy Kite Pharma for Roughly $11 Billion -- Update	NASDAQ:KITE	Kite Pharma, Inc.
28/08/2017	13h00	Business Wire	Gilead Sciences to Acquire Kite Pharma for $11.9 Billion	NASDAQ:KITE	Kite Pharma, Inc.
28/08/2017	12h59	Dow Jones News	Gilead to Buy Kite Pharma for Roughly $11 Billion in Cash	NASDAQ:KITE	Kite Pharma, Inc.
17/08/2017	14h30	Business Wire	Kite Highlights Publication from the National Cancer Institute Demonstrating Responses in Patients with Metastatic Solid Tumo...	NASDAQ:KITE	Kite Pharma, Inc.
14/08/2017	23h10	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:KITE	Kite Pharma, Inc.